Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart weaning: could a machine do better than doctors for tiny lungs?

NCT ID NCT06832163

First seen May 13, 2026 · Last updated May 25, 2026 · Updated 2 times

Summary

This study tests a new 'smart weaning' feature on a machine that delivers inhaled nitric oxide to newborns with persistent pulmonary hypertension (PPHN). The device automatically lowers the gas dose in a steady, controlled way, instead of relying on manual adjustments by nurses and doctors. Researchers want to see if this automated approach is safe, reduces the risk of oxygen drops, and cuts down on staff workload. About 30 newborns whose treatment is expected to last 24 hours or more will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital of Fudan University

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.